ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FUM Futura Medical Plc

33.80
-1.05 (-3.01%)
Last Updated: 14:00:58
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.05 -3.01% 33.80 33.85 34.65 34.75 33.80 34.25 199,046 14:00:58
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -17.42 101.64M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 34.85p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £101.64 million. Futura Medical has a price to earnings ratio (PE ratio) of -17.42.

Futura Medical Share Discussion Threads

Showing 13051 to 13068 of 21425 messages
Chat Pages: Latest  533  532  531  530  529  528  527  526  525  524  523  522  Older
DateSubjectAuthorDiscuss
16/8/2022
12:01
All Futura have done is also allow Reckitt to sell lubricants/arousal gels as medical device placebo treatments for ED. And report Med3000 to the ASA, FTC etc for being misleading if it doesn't inform consumers that Med3000 itself has no proven effect in ED beyond a placebo. As it has not proven efficacy in a placebo controlled study or even against any standard cooling lubricant/arousal gels.https://neo.life/2021/10/the-promise-of-pills-that-do-nothing/'You are the active ingredient'How long before Reckitt puts the final nail in the coffin?https://www.globenewswire.com/en/news-release/2022/03/17/2405009/28124/en/Global-Personal-Lubricant-Market-Outlook-Forecast-Report-2022-2027-Featuring-Prominent-Vendors-LifeStyles-Church-Dwight-Karex-Berhad-Reckitt-Benckiser-Group-BioFilm.htmlReckitt Benckiser was the defined leader and the ultimate four Personal lubricant vendors with leading brands such as Durex Play and K-Y Jelly.KEY GROWTH FACTORSIncreasing prevalence of erectile dysfunction9 Market Growth Enablers9.1 Increasing Prevalence of Erectile Dysfunctionhttps://amp.theguardian.com/business/shortcuts/2015/dec/14/how-bad-was-what-nurofen-did-austalian-courtsFor many, whether or not placebo use is ethical depends partly on whether patients are being deceived and whether there is a known better treatment.A clinician who doesn’t t deceive a patient, and who provides a placebo for something for which there is no known treatment, such as irritable bowel syndrome, might be ethically OK, says Jeremy Howick, of the Department of Primary Health Care Sciences, at the University of Oxford, and lead author of the Plos One study. â€Å"But there is no evidence that this company is enhancing care. What they’ve been doing is completely unethical
lbo
16/8/2022
11:58
325 million men the lbo says do no exist



ROFLMAO

j777j
16/8/2022
11:53
Lbo's anal prolapse is on the floor he is on so much overtime
j777j
16/8/2022
11:53
I wonder how big a lie the ASA, EU courts and FTC will say this is? One thing is for sure. Companies need a lot of cash to market a placebo and fight the lawsuits and paying the fines like the FTC judgements



Placebo-nomics: how bad was what Nurofen did?

Australian courts have ordered the makers of the brand to stop repackaging identical painkillers for different pains where does marketing end and deception begin?

Lies come in a wide range of ethical shapes and sizes. There are white ones, diplomatic ones, and there are mean, self-serving ones. Apparently there are even nice, Christmassy ones.

The Australian federal court yesterday ordered the drug giant Reckitt Benckiser to stop selling identical products marketed as specific Nurofen varieties for back pain, period pain, migraine pain and tension headaches. The company admitted the drugs sold in different coloured packets all contained the same active ingredient: 342mg of ibuprofen lysine. It also sold them at almost twice the price of Nurofens standard ibuprofen products.
Whether this constitutes deception or just marketing is probably one for the lawyers to argue over

lbo
16/8/2022
11:51
Its all a 'swindle' by the rampers!https://pubmed.ncbi.nlm.nih.gov/19758285/the placebo effect in RCT of iPDE5 for ED occurs at a rate as high as 50%https://s4be.cochrane.org/blog/2014/10/13/richards-reviews-sham-devices-placebos/Recent research has shown that the placebo effect is not only similar for medical devices to medical trials; it is considerably larger â€" the effect of a sham device is almost three times that of an oral placebo.
lbo
16/8/2022
11:49
£65 million a week to futura turns it into the billionaires club of market cap
j777j
16/8/2022
11:48
Tried ,tested and about to become the fastest ever selling OTC topical product for ED



Fasten seatbelts

j777j
16/8/2022
11:27
You were posting similar ramps before the Phase 3 failure in 2019 and then share price collapsed below 10p LOL




J777J - 28 Nov 2019 - 07:35:10 - 6443 of 11639
New 15 page buy note out today from Liberum.

A strong positive outcome would imply 149p share

lbo
16/8/2022
11:21
The numbers are staggering.
j777j
16/8/2022
11:21
Bear in mind 10% of the 300 million men are contra indicated to the current prescription medications.

So that is 30 million men right there.





At 217p wholesale and using just once a week that is over £65 million A WEEK to Futura

j777j
16/8/2022
11:17
Our research indicates this could be worth north of 400p a share.
Based on just a 10% market share.

j777j
16/8/2022
11:13
Here is another company who made false claims about its medical device being clinically proven and that the FDA had reviewed and approved the device for its advertised pain relief and other health benefits. The FTC challenged all those claims as false and hit them with a judgement for $22 million. The FDA does not approve class 1 or 2 devices like Willow Curve and Med3000!https://www.ftc.gov/business-guidance/blog/2020/06/lights-out-unsubstantiated-pain-relief-claims-and-deceptive-native-advertisinghttps://www.ftc.gov/system/files/documents/cases/physicians_complaint.pdfhttps://www.consumerprotectionreview.com/2020/09/ftc-enters-into-22-million-settlement-with-manufacturer-of-willow-curve-regarding-unsubstantiated-pain-relief-claims-and-deceptive-native-advertising/
lbo
16/8/2022
10:53
Trinity Research even admit the hypothesised effects 'believed' to be happening by Futura are 'disputed' and they admitted no mechanism of action has to be even shown to get a medical device approved. But unfortunately it does to need be proven to substantiate its marketing claims or fall foul of the FTC, ASA etchttps://www.ftc.gov/system/files/documents/public_statements/996984/p114505_otc_homeopathic_drug_enforcement_policy_statement.pdfA product that contemporary technology does not understand must establish that this 'magic' actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer. FTC v. QT, Inc., 512 F.3d 858, 862-63 (7th Cir.Trinity research:Presumably the effect is comparable to the cold-induced vasodilation (CIVD) that occurs with extremities such as toes and fingers. Despite being a well-known effect, the mechanisms of CIVD are still disputed, but the pathways involved could well be similar. Interestingly, the precise mechanism of action does not need to be elucidated for the regulators to be comfortable for a product to be approved as medical devicehttps://www.discovermagazine.com/health/the-erection-of-a-placebo˜There is no evidence for the evaporative mode of action from the clinical trials. To show that the evaporation is what makes MED3000 work, you'd need to compare it to a non-evaporative gel’
lbo
16/8/2022
10:29
ROFLMAO

A supposed multibillion dollar golden goose with no patent protection! If the ‘magic’ does work and is not just a placebo then anyone can make a similar alcohol and water cooling gel themselves. What a pump and soon to be dumped ‘swindle’ by the rampers!



The composition of the invention contained: ethanol: 33%; water: 35%; glycerol: 24%; propylene glycol: 6%; Carbopol® Ultrez 10: 1%. pH was adjusted to 5.25 with potassium hydroxide solution. The ethanol used in the manufacture of the composition was absolute ethanol (i.e. 100% ethanol free from water) such that the final composition contained 33% of pure ethanol. If a lower grade of ethanol was used which contained impurity amounts of water (e.g. 96% ethanol), then the amount used would have to be adjusted to ensure the final composition contained the correct amount of the components, i.e. 33% pure ethanol and 35% water.





Kama Sutra Intensify Plus Female Arousal Gel Cooling 15 ml

Ingredients: Water, Propylene Glycol, Denatured Alcohol



Voltaren vehicle gel is the carrier substance of the topical Voltaren products. This vehicle gel is especially formulated to be easily applied on the skin, while providing some sensory benefits. The present study aims to substantiate the widely perceived hydrating and cooling effect of Voltaren vehicle

lbo
16/8/2022
09:08
Pfizer et Al are terrified their multi billion dollar golden goose is a kit to be taken away by a tiny UK co.
j777j
16/8/2022
09:05
The most significant breakthrough in the treatment of ED in Iver 20 years.No wonder lbo is being paid to try and deramp.This will go straight to OTC and will sell in the hundreds of millions of dollars much faster than any predictions.Worth ££££'s per share.Almost there folks just days away from release
j777j
15/8/2022
15:08
Imagine anyone can make their own alcohol and water gel and supposedly all the mild to moderate ED in the world will be solved!

No wonder Glaxo walked away for ‘normal commercial reasons! LOL



GlaxoSmithKline unexpectedly handed back the development rights to Futuras erectile dysfunction gel. We are not going to progress on this particular compound for normal commercial reasons which we do not wish to go into, GSK said.



The cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results.


Even Dermasys on its own has no patent anymore. The Dermasys trademark predates by many years the umbrella patents covering MED2005 (Dermasys and GTN) and TPR100 (Dermasys and Diclofenac) which are all expiring soon also.

from Trinity in a previous note regarding the MED2005 patent:

the long development period resulted in a material erosion of the patent life, with the original formulation patent expected to expire in 2025

Dermasys is even older so is off patent

2002 plus 20 years = 2022



The DermaSys(R) technology was originally developed by Futura for use in the Company's topical treatment for erectile dysfunction, MED2002





Under the terms of the agreement, Thornton & Ross will conduct the manufacturing scale-up of TPR100 and hold rights to manufacture, market and distribute the product in the UK for the lifetime of the product's patents, which run to at least 2028 in the UK

lbo
15/8/2022
14:32
Yep. You know when things are going well for FUM because LiarBO gets even more repetitive than usual, if such a thing is possible.
petroc
Chat Pages: Latest  533  532  531  530  529  528  527  526  525  524  523  522  Older

Your Recent History

Delayed Upgrade Clock